Literature DB >> 12461769

Neural stem cells and neuro-oncology: quo vadis?

Lawrence Recht1, Taichang Jang, Todd Savarese, N S Litofsky.   

Abstract

Conventionally, gliomas are assumed to arise via transformation of an intraparenchymal glial cell that forms a mass that then expands centrifugally, eventually invading surrounding tissues. We propose an alternative model in which gliomas arise via initiation and promotion of cells within the brain's subependymal layer or subventricular zone, the source of a recently characterized pool of neural cells with the properties of self-renewal and multipotentiality (i.e., stem cells) that persists into adulthood. In this model, the particular histological subtype of glioma would represent the effects of temporal and spatial environmental influences rather than the particular cell of origin and the disease's centrifugal point would be the subependymal layer. The implications of such a model are discussed. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12461769     DOI: 10.1002/jcb.10208

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

Review 1.  Magnetic resonance imaging characteristics of glioblastoma multiforme: implications for understanding glioma ontogeny.

Authors:  Leif-Erik Bohman; Kristin R Swanson; Julia L Moore; Russ Rockne; Christopher Mandigo; Todd Hankinson; Marcela Assanah; Peter Canoll; Jeffrey N Bruce
Journal:  Neurosurgery       Date:  2010-11       Impact factor: 4.654

2.  Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors.

Authors:  Sara Gil-Perotin; Mireya Marin-Husstege; Jiadong Li; Mario Soriano-Navarro; Frederique Zindy; Martine F Roussel; Jose-Manuel Garcia-Verdugo; Patricia Casaccia-Bonnefil
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

3.  Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma.

Authors:  Yuan Zhu; Frantz Guignard; Dawen Zhao; Li Liu; Dennis K Burns; Ralph P Mason; Albee Messing; Luis F Parada
Journal:  Cancer Cell       Date:  2005-08       Impact factor: 31.743

Review 4.  Some speculation on the origin of glioblastoma.

Authors:  Matthew R Quigley; Christopher Post; Garth Ehrlich
Journal:  Neurosurg Rev       Date:  2006-11-23       Impact factor: 3.042

5.  Roles of p53 and p27(Kip1) in the regulation of neurogenesis in the murine adult subventricular zone.

Authors:  Sara Gil-Perotin; Jeffery D Haines; Jasbir Kaur; Mireya Marin-Husstege; Michael J Spinetta; Kwi-Hye Kim; Maria Duran-Moreno; Timothy Schallert; Frederique Zindy; Martine F Roussel; Jose M Garcia-Verdugo; Patrizia Casaccia
Journal:  Eur J Neurosci       Date:  2011-09-07       Impact factor: 3.386

Review 6.  Primary brain tumors, neural stem cell, and brain tumor cancer cells: where is the link?

Authors:  Isabelle Germano; Victoria Swiss; Patrizia Casaccia
Journal:  Neuropharmacology       Date:  2010-01-01       Impact factor: 5.250

Review 7.  Calcium Channels in Adult Brain Neural Stem Cells and in Glioblastoma Stem Cells.

Authors:  Valérie Coronas; Elodie Terrié; Nadine Déliot; Patricia Arnault; Bruno Constantin
Journal:  Front Cell Neurosci       Date:  2020-11-13       Impact factor: 5.505

8.  Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells in vitro and in vivo.

Authors:  Hua Chen; Qiang Huang; Jun Dong; De-Zhong Zhai; Ai-Dong Wang; Qing Lan
Journal:  BMC Cancer       Date:  2008-01-29       Impact factor: 4.430

9.  Brain cancer stem cells: current status on glioblastoma multiforme.

Authors:  Sabrina Facchino; Mohamed Abdouh; Gilbert Bernier
Journal:  Cancers (Basel)       Date:  2011-03-30       Impact factor: 6.639

10.  The top cited articles on glioma stem cells in Web of Science.

Authors:  Fuxin Yi; Jun Ma; Weimin Ni; Rui Chang; Wenda Liu; Xiubin Han; Dongxiao Pan; Xingbo Liu; Jianwu Qiu
Journal:  Neural Regen Res       Date:  2013-05-25       Impact factor: 5.135

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.